An effective complaint handling system is an extremely important part of any quality system. Manufacturers should understand that any complaint received on a product shall be evaluated and, if necessary, thoroughly investigated and analysed, and corrective action shall be taken.
The results of this evaluation should lead to a conclusion regarding whether the complaint was valid, what the root cause of the complaint was, and what action is necessary to prevent further occurrences. Complaints cannot be ignored. They are an excellent indicator of problems with the use, design, and/or manufacture of a product. A single complaint that is thoroughly investigated may lead a company to take remedial or corrective action. It may also take an ongoing analysis of numerous complaints before a trend is spotted that causes a company to initiate changes in their product, labelling, packaging or distribution. The regulatory expectations for both pharmaceuticals and medical devices will be emphasized as well as overview of best practices for timely and effective investigations. Trending is the only way a company can stay on top of emerging quality issues and address those that are most pressing.
Medical Device Reporting (MDR) is the mechanism for FDA to receive significant medical device adverse events from manufacturers, importers and user facilities, so they can be detected and corrected quickly. User Facilities (e.g., hospitals, nursing homes) are required to report suspected medical device related deaths to both the FDA and the manufacturers. User facilities report medical device related serious injuries only to the manufacturer. If the medical device manufacturer is unknown, the serious injury is reported by the facility to FDA. Health professionals within a user-facility should familiarize themselves with their institution procedures for reporting adverse events to the FDA.
A medical device recall does not always mean that you must stop using the product or return it to the company. A recall sometimes means that the medical device needs to be checked, adjusted, or fixed. If an implanted device (for example, a pacemaker or an artificial hip) is recalled, it does not always have to be removed. When an implanted device has the potential to fail unexpectedly, companies often tell doctors to contact their patients to discuss the risk of removing the device compared to the risk of leaving it in place. FDA classifies medical device recalls into three categories, representing the potential risk to public health: Class I, II, and III.
Meet your Expert:
David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, provides guidance on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses global regulatory requirements. Background encompasses broad capabilities in quality systems, validation, regulatory affairs, compliance, auditing, interfacing with the regulatory agencies, addressing enforcement actions and mitigating compliance exposure for companies via remediation, compliance engineering support, post-marketing surveillance and vigilance reporting; clinical affairs, establish and/or remediate Quality Management and documentation systems for GxP compliance; preparation for ISO 13485 registration and CE Mark; and multi-country product registrations and licensing; and working with Notified Bodies, and AR's.
Regulatory Affairs Management, Regulatory Affairs Specialist, Auditors, Compliance Officer, Compliance Specialist, Clinical Affairs, Quality Assurance Management, Marketing & Sales, Distributors/Authorized Representatives, Legal Counsel, Engineering/Technical Services, Operations/Manufacturing, Consultants
RAC Credits: 12
Date: September 29th & 30th, 2014
Event Details: http://bit.ly/Y7J4ef
Location: Zurich, Switzerland
Venue: Hilton Zurich Airport, Hohenbuehlstrasse 10, 8152 Opfikon-Glattbrugg
Registration: Open Enrollment
Delivery: Face-to-Face event
Until August 25, Early Bird Price: $1,595.00
From August 26 to September 27, Regular Price: $1,795.00
Understand that although FDA does not specify a standard complaint handling system, the requirements do specify certain actions that shall be included in any system. Determine when a recall is required and how to manage a recall, who must report, when to report, what to report, where to report, recordkeeping requirements, FDA regulatory authority, references and guidance. Seminar attendees are encouraged to bring examples of their work from the functional area on the various topics as applicable for group discussion.
Course Web Site: https://www.globalcompliancepanel.com/control/~product_id=900114SEMINAR
161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA
GlobalCompliancePanel imparts knowledge of best practices in industry to guarantee effective implementation of compliance programs for meeting regulatory demands. The key focus of GlobalCompliancePanel is to provide extensive and quality training for risk management, regulatory compliances, corporate governance and quality management.
Over 300 Experts that are Renowned in their Respective Areas
Successfully Trained more than 20,000 Compliance Professionals
A Most Comprehensive Portal for Trainings, Industry Updates and Professional Growth
Having more than 2000 Online Courses
Successfully Completed more than 170 Seminars in US and Globally